Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)

CUSIP: 52886X107

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
74,507,639
Total 13F shares
16,174,480
Share change
+16,174,480
Total reported value
$217,090,546
Price per share
$13.42
Number of holders
31
Value change
+$217,090,546
Number of buys
31

Quarterly Holders Quick Answers

What is CUSIP 52886X107?
CUSIP 52886X107 identifies LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LXEO - Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Longitude Capital Partners IV, LLC
3/4/5
10%+ Owner —
class O/S missing
2,567,100
 $33,933,468 — 07 Nov 2023
3/4/5
Omega Fund VI, L.P.
3/4/5
10%+ Owner —
class O/S missing
2,157,623
 $28,520,755 — 07 Nov 2023
3/4/5
Invest A/s Lundbeckfond
3/4/5
10%+ Owner —
class O/S missing
1,835,959
 $24,268,808 — 07 Nov 2023
3/4/5
Paul McCormac
3/4/5
Chief Technical Officer —
class O/S missing
17,349
 $229,329 — 07 Nov 2023
3/4/5

Institutional Holders of Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO) as of Q4 2023

As of 31 Dec 2023, Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,174,480 shares. The largest 10 holders included EVENTIDE ASSET MANAGEMENT, LLC, D1 Capital Partners L.P., JANUS HENDERSON GROUP PLC, Omega Fund Management, LLC, CITADEL ADVISORS LLC, Novo Holdings A/S, Blackstone Inc., Artal Group S.A., VANGUARD GROUP INC, and Laurion Capital Management LP. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q4 2025 Across Filers

Q4 2025 holders
145
Q4 2023 holders
31
Holder diff
-114
Investor Q4 2025 Shares Q4 2023 Shares Share Diff Share Chg % Q4 2025 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .